Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients

Documenti analoghi

• Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
  di: Daniella Kushnir‐Grinbaum, et al.
  Pubblicazione: (2025)
• Health‐related quality of life of adult and adolescent patients living with alopecia areata in Australia
  di: Rodney Sinclair, et al.
  Pubblicazione: (2024)
• Australian dermatologists' prescribing behaviours for female androgenetic alopecia
  di: Anneliese Willems, et al.
  Pubblicazione: (2024)
• Tick bite‐induced alopecia areata‐like effluvium
  di: Rodrigo Peñuelas Leal, et al.
  Pubblicazione: (2024)
• Is tofacitinib monotherapy also effective for the treatment of Acrodermatitis continua of Hallopeau?
  di: Danxiang Shen, et al.
  Pubblicazione: (2024)